Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bandopadhayay, Pratiti"'
Autor:
Cohen KJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Munjapara V; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Aguilera D; Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia., Castellino RC; Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia., Stapleton SL; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida., Landi D; Department of Pediatrics, The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Duke University Medical Center, Durham, North Carolina., Ashley DM; Department of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Duke University Medical Center, Durham, North Carolina., Rodriguez FJ; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Hawkins C; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, The University of Toronto, Toronto, Canada., Yang E; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts., London W; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Chi S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Department of Pediatrics, Harvard Medical School, Broad Institute of MIT and Harvard, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5031-5037.
Autor:
Blandin AF; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Giglio R; Dana-Farber Cancer Institute, Boston, Massachusetts., Graham MS; Memorial Sloan Kettering Cancer Center, New York, New York., Garcia G; Dana-Farber Cancer Institute, Boston, Massachusetts., Malinowski S; Dana-Farber Cancer Institute, Boston, Massachusetts., Woods JK; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Ramkissoon S; Dana-Farber Cancer Institute, Boston, Massachusetts., Ramkissoon L; Dana-Farber Cancer Institute, Boston, Massachusetts., Dubois F; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Schoolcraft K; Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai J; Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Wang D; Dana-Farber Cancer Institute, Boston, Massachusetts., Jones R; Dana-Farber Cancer Institute, Boston, Massachusetts., Vogelzang J; Dana-Farber Cancer Institute, Boston, Massachusetts., Pelton K; Dana-Farber Cancer Institute, Boston, Massachusetts., Becker S; Dana-Farber Cancer Institute, Boston, Massachusetts., Watkinson F; Dana-Farber Cancer Institute, Boston, Massachusetts., Sinai C; Dana-Farber Cancer Institute, Boston, Massachusetts., Cohen EF; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Haemels V; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Goumnerova L; TromboProtea, Inc, Weston, Massachusetts., Wright K; Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Kieran M; Day One Biopharmaceuticals, Brisbane, California., Fehnel K; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Reardon D; Dana-Farber Cancer Institute, Boston, Massachusetts., Tauziede-Espariat A; GHU Paris, Sainte-Anne Hospital, Paris, France., Lulla R; Hasbro Children's Hospital, Providence, Rhode Island., Carcamo B; Texas Tech University, Health Science Center, Paul L. Foster School of Medicine, El Paso, Texas.; El Paso Children's Hospital, El Paso, Texas., Chaleff S; Maine Medical Center, Portland, Maine., Charest A; Beth Israel Deaconess Medical Center, Boston, Massachusetts., De Smet F; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Ligon AH; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Dubuc A; Dana-Farber Cancer Institute, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Pages M; Department of Genetics, Institute Curie, Paris, France.; INSERM U830, Laboratory of Translational Research in Pediatric Oncology, SIREDO Pediatric Oncology Center, Institute Curie, Paris, France., Varlet P; GHU Paris, Sainte-Anne Hospital, Paris, France., Wen PY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Alexander BM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chi S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Alexandrescu S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Kittler R; University of Texas Southwestern Medical Center, Dallas, Texas., Bachoo R; University of Texas Southwestern Medical Center, Dallas, Texas., Bandopadhayay P; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Beroukhim R; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Ligon KL; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts.; Dana-Farber Cancer Institute, Center for Patient-Derived Models (CPDM), Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 14; Vol. 29 (14), pp. 2651-2667.
Autor:
Bandopadhayay P; Authors' Affiliations: Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Pediatric Neuro-Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology/Oncology, Boston Children's Hospital; Center for Cancer Genome Characterization, Dana-Farber Cancer Institute, Boston; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Departments of Neurology and Neurological Sciences and Neurosurgery, Stanford University School of Medicine; Stanford Cancer Institute, Stanford University Medical Center, Stanford; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla; Department of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, California; and Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Feb 15; Vol. 20 (4), pp. 912-25. Date of Electronic Publication: 2013 Dec 02.